GLSI
HEALTHCAREGreenwich Lifesciences Inc
AI Insight
What's Moving GLSI Today?
No stock-specific AI insight has been generated for GLSI yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$7.78$34.10
$23.03
Fundamentals
Market Cap$349M
P/E Ratio—
EPS$-1.61
Dividend Yield—
Dividend / Share—
ROE-677.0%
Profit Margin—
Debt / Equity—
Trading
Volume72K
Avg Volume (10D)—
Shares Outstanding14.7M
GLSI News
24 articles- Greenwich Lifesciences Inc (GLSI) Shareholder Structure: Major Shareholders & Institutional HoldingsTradingKey·Jun 17, 2026
- Greenwich Lifesciences Inc (GLSI) Revenue Breakdown: Business Segments, Regional Revenue & Profit ContributionTradingKey·Jun 17, 2026
- Greenwich LifeSciences, Inc. Q1 2026 Quarterly Report: Financials, Risk Factors, and Disclosure HighlightsMinichart·Jun 5, 2026
- Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at ASCO Meeting 2026Yahoo Finance·Jun 1, 2026
- GLSI Stock Climbs After Removing A Key Overhang – Retail Turns Focus To High-Stakes Breast Cancer TrialStocktwits·Jun 1, 2026
- Greenwich Lifesciences Provides Update Regarding Form 10-K FilingTradingView·Jun 1, 2026
- Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q FilingYahoo Finance·May 22, 2026
- Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026GlobeNewswire Inc.·Apr 23, 2026
- Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K FilingGlobeNewswire Inc.·Apr 22, 2026
- Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026GlobeNewswire Inc.·Apr 20, 2026
- Greenwich LifeSciences Provides Update on Financing StrategyYahoo Finance·Apr 14, 2026
- Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market PotentialGlobeNewswire Inc.·Apr 7, 2026
- Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01Yahoo Finance·Mar 19, 2026
- Greenwich LifeSciences Provides Update on Upcoming AACR MeetingYahoo Finance·Mar 18, 2026
- Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01Yahoo Finance·Mar 17, 2026
- Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01Yahoo Finance·Mar 16, 2026
- Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01Yahoo Finance·Mar 3, 2026
- Greenwich LifeSciences Announces Acceptance of Two Abstracts at AACR Annual Meeting 2026Yahoo Finance·Feb 24, 2026
- Greenwich LifeSciences Provides Update on FLAMINGO-01 Cash Burn Rate and Financing StrategyYahoo Finance·Jan 27, 2026
- Insiders of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) must be frustrated after market cap dropped US$50m since recent purchasesYahoo Finance·Jan 23, 2026
- Sector Update: Health Care Stocks Mixed Late AfternoonYahoo Finance·Jan 22, 2026
- Top Midday GainersYahoo Finance·Jan 22, 2026
- Wall Street Set to Open Higher Thursday as Investors Parse GDP, Unemployment Data, Look Ahead to Inflation ReportYahoo Finance·Jan 22, 2026
- Investors Await Raft of Key Economic Data as US Futures Rise Thursday Pre-BellYahoo Finance·Jan 22, 2026
All 24 articles loaded
Price Data
Open$23.66
Previous Close$23.03
Day High$23.99
Day Low$22.91
52 Week High$34.10
52 Week Low$7.78
52-Week Range
$7.78$34.10
$23.03
Fundamentals
Market Cap$349M
P/E Ratio—
EPS$-1.61
Dividend Yield—
Dividend / Share—
ROE-677.0%
Profit Margin—
Debt / Equity—
Trading
Volume72K
Avg Volume (10D)—
Shares Outstanding14.7M
About Greenwich Lifesciences Inc
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development of new cancer immunotherapies for breast and other HER2 / neu-expressing cancers. The company is headquartered in Stafford, Texas.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeCommon Stock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—